Gold Nanoparticles Enhancing Generation of ROS for Cs-137 Radiotherapy

Area of Science:

• Nanomedicine
• Radiation Oncology
• Cell Biology

Background:

• Radiotherapy uses radiation to treat cancer, often by inducing DNA damage and reactive oxygen species (ROS).
• Gold nanoparticles (GNPs) are explored as radiosensitizers due to their biocompatibility and high atomic number (Z=79).
• GNP's high-Z property may enhance ROS generation when irradiated by high-energy photons.

Purpose of the Study:

• To investigate the radiobiological effects of 55-nm GNPs on A431 cells irradiated with Cs-137 gamma rays.
• To assess GNP-enhanced ROS production and its downstream effects on cellular structures.
• To determine the radiosensitization enhancement factor (REF) of GNPs.

Main Methods:

• A431 cells were treated with 55-nm GNPs and irradiated using Cs-137 gamma rays.
• Laser scanning confocal microscopy (LSCM) was used to visualize ROS expression.
• Cellular damage, including cytoskeleton disruption and mitochondrial dysfunction, was assessed.
• Cell survival fraction curves were analyzed to calculate the radiosensitization enhancement factor.

Main Results:

• Irradiated cells with GNPs showed excessive ROS expression compared to controls.
• Significant disruption of cytoskeletons and mitochondrial dysfunction were observed following irradiation and GNP uptake.
• A radiosensitization enhancement factor (REF) of 1.29 was calculated at a 30% cell survival fraction.

Conclusions:

• GNPs significantly enhance the tumoricidal efficacy of Cs-137 radiotherapy by promoting ROS production.
• GNPs act as effective radiosensitizers, particularly for radioresistant tumor cells.
• The enhanced ROS generation pathway highlights GNPs' potential in cancer treatment.